Determination of Praziquantel in Human Plasma by HPLC and Bioequivalence of Praziquantel Tablets

Jinsong Ding
2009-01-01
Abstract:Objective To establish an HPLC method for the determination of praziquantel in the theplasma and evaluate the bioequivalence of the 2 praziquantel tablets.Methods Praziquantel was separated on a NUCLEODUR100-5 C18 column with a mixture of acetonitrile-H2O-tetrahydrofuran(51∶47∶2,v/v/v) as the mobile phase,and the internal standard was diazepam.A single oral dose of 1.2 g praziquantel was administered to 24 healthy volunteers in a randomized crossover study,and the pharmacokinetics and bioavailability were studied.Results The calibration curve was linear at 25~3 200 μg·L-1,with r2 = 0.999 4,the absolute recovery was 99.4%~115.0%(n=20),and the method recovery was 104.3%~119.9%(n=15).Inter-day RSD was 2.3%(n=15) and intra-day RSD6.9%(n=15).The relative bioavailability of tablet T was 104.0%±24.8%.Conclusion The established method is accurate and sensible for the determination of praziquantel in human plasma.The two tablets are bioequivalence.
What problem does this paper attempt to address?